Pharmaceutical products company Charles River Laboratories International (NYSE:CRL) disclosed on Friday the completion of the acquisition of Celsis International for a purchase price of USD212m in cash, subject to certain post-closing working capital adjustments.
Using its Financial Impact Assessment (FIA), Celsis works with hundreds of manufacturing facilities around the world to evaluate the cost savings of implementing a Celsis system.
Celsis will not only validate VistaGen's stem cell-derived liver cells in traditional pharmaceutical metabolism assays, but will also determine genetic variations in VistaGen's pluripotent stem cell lines that are important to drug development.
For example, the company discussed below implemented the Celsis system in 1996 and now uses the technology worldwide.
11 January 2012 - Celsis In Vitro Inc said on Tuesday that the US Court of Appeals in Washington, DC upheld a preliminary injunction against Life Technologies Corporation (NASDAQ:LIFE), or LTC, in a patent infringement case relating to US Patent No 7,604,929 covering Celsis IVT's LiverPool products.
There is the option of outsourcing rapid microbial detection to Celsis Analytical Services.
The reading from the Celsis Bacterial Counter, which measures living micro-organisms came out at 2,209.
Celsis International Plc, the microbial risk management group, have now launched a new product for hygiene monitoring.
The nexgen-PTS expands its Microbial Solutions offering within its rapid microbiology portfolio and includes microbial detection (acquisition of Celsis International), bioburden testing (PTS Micro) and microbial identification (acquisition of Accugenix).
Celsis recently worked with an independent, high-end skin care company that tests its products at the raw material, in-process and finished goods stages.
Celsis International plc--a provider of life science products and laboratory services to the pharmaceutical, biopharmaceutical, and consumer products industries--out lines the key steps the pharmaceutical industry should take to ensure they are ready to address these harmonization changes.
As pharmaceutical companies downsize their operations to save costs further, they also outsource some of their analytical and development services to companies like Celsis Intl.